Month: November 2021
-
Is Facebook a Good Company for Share Investments?
If you want to invest in a tech giant these days, Facebook is likely one of your top choices.
-
Joint Venture to Develop Stable RNA Covid-19 Vaccine
A developer of synthetic bio-based products from engineered yeast cells is joining with an immunotherapy drug maker to produce a stable RNA Covid-19 vaccine.
-
Infographic – Post-Covid CO2 Emissions Rebound
As the world’s economy recovers from pandemic restrictions, rising carbon dioxide emissions are also contributing to the global climate crisis.
-
Alphabet Forms AI Drug Discovery Company
Alphabet, the parent company of Google, is forming a new enterprise using artificial intelligence techniques to discover new protein-based drugs.
-
Cell Therapy Biotech Raises $75.5M in Venture Funds
A developer of off-the-shelf genetically engineered platelet cells to treat a range of diseases is raising $75.5 million in its second venture round.
-
Synthetic Protein Company Gains $25M in New Funds
A company designing engineered proteins to work better than natural chemistries as treatments for disease is raising $25 million in its first venture round.
-
Data Partnership Aims for Precise Parkinson’s Care
A medical device maker is offering brain stimulation data to a neurological software company to provide personalized care for people with Parkinson’s disease.
-
Hydrogel Obesity Capsule Shown to Protect Gut Tissue
Lab tests show an ingestible hydrogel designed to encourage weight loss by acting like raw vegetables helps protect and regulate intestinal tissue.